|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 25/36 | |
| A61P 25/04 | |||
| A61K 31/485 |
| (11) | Number of the document | 3215223 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15828368.9 |
| Date of filing the European patent application | 2015-11-06 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/002269 |
| Date | 2015-11-06 |
| (87) | Number | WO 2016/071767 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 201462076854 P | 2014-11-07 | US | |
| 201562100391 P | 2015-01-06 | US | |
| 201562112546 P | 2015-02-05 | US | |
| 201562199778 P | 2015-07-31 | US |
| (72) |
NASSER, Azmi, US
LAFFONT, Celine Marielle, US
HEIDBREDER, Christian Arthur, US
|
| (73) |
Indivior UK Limited,
The Chapleo Building Henry Boot Way, Priory Park Hull HU4 7DY,
GB
|
| (54) | BUPRENORPHINE DOSING REGIMENS |
| BUPRENORPHINE DOSING REGIMENS |